You are here:

teduglutide (Revestive)

Advice

in the absence of a submission from the holder of the marketing authorisation:

teduglutide (Revestive®) is not recommended for use within NHS Scotland.

Indication under review:  for the treatment of adult patients with Short Bowel Syndrome.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: teduglutide (Revestive)
SMC Drug ID: 1139/16
Manufacturer: NPS Pharma UK Ltd
Indication: for the treatment of adult patients with Short Bowel Syndrome.
BNF Category:
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 7 February 2016

Back